This metabolite incorporates a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 roughly fifty% with the guardian drug. Plasma concentrations of this metabolite are approximately forty% of These witnessed for sildenafil, so that the metabolite accounts for approximately twenty% of sildenafil's pharmacologic outcomes.Viag